Calcium: An essential mineral

Journal of Evidence-Based Complementary and Alternative Medicine

Volumn 16, Issue 1, 2011, Pages 138-144

  MacKowiak, Elaine D ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Adverse effects; Calcium homeostasis; Calcium supplementation; Daily calcium intake recommendations

Indexed keywords

EID: 79957960005     PISSN: 21565872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Constanzo LS. Physiology. 4th ed. Philadelphia, PA: WB Saunders; 2010.
2. Akerstrom G, Hellman P, Hessman O, Segersten U, Westin G. Parathyroid glands in calcium regulation and human disease. Ann N Y Acad Sci. 2005;1040:53-58.
3. Perez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta Lopez MA, Tolosa de Talamoni NG. Minireview on regulation of intestinal calcium absorption. Digestion. 2008;77:22-34.
4. Portale AA, Lonergan ET, Tanney DM, Halloran BP. Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men. Am J Physiol. 1997;272:E139-E146.
5. Blanchard J, Aeschlimann JM. Calcium absorption in man. J Pharmacokinet Biopharm. 1989;17:631-644.
6. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. http://www.iom.edu/Reports/2010/Dietary-Refer-ence-Inakes-for-Calcium-an d-Vitamin-D.aspx. AccessedNovember 30, 2010.
7. Office of Dietary Supplements. National Institutes of Health. Dietary supplement fact sheet: calcium. http://ods.od.nih.gov/ factsheets/calcium.asp. Accessed April 4, 2010.
8. Heaney RP, Dowell MS, Bierman J, Hale CA, Bendich A. Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr. 2001;20:239-246.
9. Heaney RP, Recker RR, Watson P, Lappe JM. Phosphate and carbonate salts of calcium support robust bone building in osteoporosis. Am J Clin Nutr. 2010;92:101-105.
10. Nordin BEC, Need AG, Morris HA, O'Loughlin PD, Horowitz M. Effect of age on calcium absorption in postmenopausal women. Am J Clin Nutr. 2004;80:998-1002.
11. Greenwald DA. Aging, the gastrointestinal tract, and risk of acid-related disease. Am J Med. 2004;117(suppl 5A):8S-13S.
12. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor use and risk of hip fractures. JAMA. 2006;296: 2947-2953.
13. Gray SL, LaCroix AZ, Larson J, et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopau-sal women. Arch Intern Med. 2010;170:765-771.
14. Carmeliet G, Van Cromphaut S, Daci E, Maes C, Bouillon R. Disorders of calcium homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:529-546.
15. Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N Y Acad Sci. 2006;1092:385-396.
16. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008;93:861-868.
17. Seeman E. Invited review: Pathogenesis of osteoporosis. J Appl Physiol. 2003;95:2142-2151.
18. Tuck SP, Datta HK. Osteoporosis in the aging male: treatment options. Clin Interv Aging. 2007;2:521-536.
19. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000;106:1553-1556.
20. von Muhlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R. Effect of dehydroepiandosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteroporosis Int. 2008;19: 699-707.
21. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
22. Bostrom K. Insights into the mechanism of vascular calcification. Am J Cardiol. 2001;88(2 supp 1):20-22.
23. Alexopoulos N, Raggi P. Calcification in atherosclerosis. Nat Rev Cardiol. 2009;6:681-688.
24. Wilson PWF, Nam BH, Pencina M, D'Agostino RB, Benjamin EJ, ODonnell CJ. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med. 2005;165:2473-2478.
25. Johnson KM, Dowe DA. The detection of any coronarycalcium outperforms Framingham risk score as a first step in screening for coronary atherosclerosis. AJR Am J Roentgenol. 2010;194:1235-1243.
26. Polonsky TS, McCelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1210-1216.
27. McEvoy JW, Blaha MJ, DeFilippis AP, et al. Coronary artery calcium progression: an important clinical measurement. J Am Coll Cardiol. 2010;56:1613-1622.
28. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:483-495.
29. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). J Am Coll Cardiol. 2007;49:378-402.
30. US Food and Drug Administration. Whole-body CT screening- Should I or shouldn't I get one? http://www.fda.gov/Radiation-EmittingProducts/RadiationEmittingProductsa ndProcedures/ MedicalImaging/MedicalX-Rays/ucm115330.htm. Accessed November 3, 2010.
31. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D: supplementation and the risk of fractures. N Engl J Med. 2006; 354:669-683.
32. Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846-854.
33. Shah SM, Carey IM, Harris T, DeWilde S, Cook DG. Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf. 2010;19:59-64.
34. Manson JE, Allison MA, Carr J, et al. Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause. 2010;17:683-691.
35. Reid IR, Bolland MJ. Calcium supplementation and vascular disease. Climateric. 2008;11:280-286.
36. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. doi:10.1136/bmj. c3691.
37. ClinicalTrials.gov. Trial to assess chelation therapy (TACT). http://clinicaltrials.gov/ct2/show/NCT00044213?term1/4chelation &rankth1. Accessed November 10, 2010.
38. National Center for Complementary and Alternative Medicine. Questions and answers: The NIH trial of EDTA chelation therapy for coronary artery disease. http://nccam.nih.gov/health/chela-tion/. Accessed November 10, 2010.
39. Baxter AJ, Krenzelok EP. Pediatric fatality secondary to EDTA chelation. Clin Toxicol (Phila). 2008;46:1083-1084.
40. US Food and Drug Administration. FDA warns marketers of unapproved "chelation" drugs. http://www.fda.gov/ForConsu-mers/ConsumerUpdates/ucm229358.htm. Accessed October 15, 2010.
41. US Food and Drug Administration. Qualified health claims: Letter regarding calcium and colon/rectal, breast, and prostate cancers and recurrent colon polyps (Docket No. 2004Q-0097). http://www.fda.gov/Food/LabelingNutrition/LabelClaims/Quali-fiedHealthCl aims/ucm072771.htm. Accessed October 22, 2010.
42. National Cancer Institute. Calcium and cancer prevention: strengths and limits of the evidence. http://www.cancer.gov/cancertopics/ factsheet/prevention/calcium. Accessed October 22, 2010.
43. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenoma. N Engl J Med. 1999;340: 101-107.
44. Weingarten MA, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev. 2008;1:CD003548.
45. Half E, Arber N. Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother. 2009;10: 211-219.
46. Mitrou PN, Albanes D, Weinstein SJ, et al. A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland). Int J Cancer. 2007;120:2466-2473.
47. Park Y, Mitrou PN, Kipnis V, Hollenbeck A, Schatzkin A, Leitzmann MF. Calcium, dairy foods, and risk of incident and fatal prostate cancer. Am J Epidemiol. 2007;166:1270-1279.
48. Chakravarti B, Dwivedi SK, Mithal A, Chattopadhyay N. Calcium-sensing receptor in cancer: good cop or bad cop? Endocrine. 2009;35:271-284.
49. Medarov BI. Milk-alkali syndrome. Mayo Clin Proc. 2009;84: 261-267.
50. Mattle D, Hess B. Preventative treatment of nephrolithiasis with alkali citrate-a critical review. Urol Res. 2005;33:73-79.
51. Heaney RP, Dowell MS, Barger-Lux MJ. Absorption of calcium as the carbonate and citrate salts, with some observations on method. Osteoporosis Int. 1999;9:19-23.
52. Heaney RP. Calcium supplementation and incident kidney stone risk: a systematic review. J Am Coll Nutr. 2008;27:519-527.